Cargando…
影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展
With the progress of targeted therapy and immunotherapy for lung cancer, the clinical demand for lung biopsy is increasing. An ideal biopsy specimen can be used not only for histopathological diagnosis, but also for biomarker detection. The ideal biopsy specimen should meet two requirements, includi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558762/ https://www.ncbi.nlm.nih.gov/pubmed/37752543 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.15 |
_version_ | 1785117351198326784 |
---|---|
author | BAI, Gengshen ZHU, Bingyin MA, Jun LI, Yongchun HUANG, Gang MA, Yaqiong |
author_facet | BAI, Gengshen ZHU, Bingyin MA, Jun LI, Yongchun HUANG, Gang MA, Yaqiong |
author_sort | BAI, Gengshen |
collection | PubMed |
description | With the progress of targeted therapy and immunotherapy for lung cancer, the clinical demand for lung biopsy is increasing. An ideal biopsy specimen can be used not only for histopathological diagnosis, but also for biomarker detection. The ideal biopsy specimen should meet two requirements, including more than 60 mm(2) of tumor tissue and containing more than 20% of tumor cells. In order to obtain ideal lung cancer biopsy specimens, advanced imaging techniques are needed to help. In this article, we reviewed the requirements for biopsy specimens based on biomarker detection, as well as the current status and research progress of using imaging techniques for preoperative planning and intraoperative real time guidance of lung cancer biopsy. |
format | Online Article Text |
id | pubmed-10558762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Editorial board of Chinese Journal of Lung Cancer |
record_format | MEDLINE/PubMed |
spelling | pubmed-105587622023-10-08 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 BAI, Gengshen ZHU, Bingyin MA, Jun LI, Yongchun HUANG, Gang MA, Yaqiong Zhongguo Fei Ai Za Zhi Review With the progress of targeted therapy and immunotherapy for lung cancer, the clinical demand for lung biopsy is increasing. An ideal biopsy specimen can be used not only for histopathological diagnosis, but also for biomarker detection. The ideal biopsy specimen should meet two requirements, including more than 60 mm(2) of tumor tissue and containing more than 20% of tumor cells. In order to obtain ideal lung cancer biopsy specimens, advanced imaging techniques are needed to help. In this article, we reviewed the requirements for biopsy specimens based on biomarker detection, as well as the current status and research progress of using imaging techniques for preoperative planning and intraoperative real time guidance of lung cancer biopsy. Editorial board of Chinese Journal of Lung Cancer 2023-08-20 /pmc/articles/PMC10558762/ /pubmed/37752543 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.15 Text en 版权所有 © 2023《中国肺癌杂志》编辑部 https://creativecommons.org/licenses/by/3.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/. |
spellingShingle | Review BAI, Gengshen ZHU, Bingyin MA, Jun LI, Yongchun HUANG, Gang MA, Yaqiong 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 |
title | 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 |
title_full | 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 |
title_fullStr | 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 |
title_full_unstemmed | 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 |
title_short | 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 |
title_sort | 影像计划和实时引导肺癌穿刺活检在生物标志物检测中的进展 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558762/ https://www.ncbi.nlm.nih.gov/pubmed/37752543 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.15 |
work_keys_str_mv | AT baigengshen yǐngxiàngjìhuàhéshíshíyǐndǎofèiáichuāncìhuójiǎnzàishēngwùbiāozhìwùjiǎncèzhōngdejìnzhǎn AT zhubingyin yǐngxiàngjìhuàhéshíshíyǐndǎofèiáichuāncìhuójiǎnzàishēngwùbiāozhìwùjiǎncèzhōngdejìnzhǎn AT majun yǐngxiàngjìhuàhéshíshíyǐndǎofèiáichuāncìhuójiǎnzàishēngwùbiāozhìwùjiǎncèzhōngdejìnzhǎn AT liyongchun yǐngxiàngjìhuàhéshíshíyǐndǎofèiáichuāncìhuójiǎnzàishēngwùbiāozhìwùjiǎncèzhōngdejìnzhǎn AT huanggang yǐngxiàngjìhuàhéshíshíyǐndǎofèiáichuāncìhuójiǎnzàishēngwùbiāozhìwùjiǎncèzhōngdejìnzhǎn AT mayaqiong yǐngxiàngjìhuàhéshíshíyǐndǎofèiáichuāncìhuójiǎnzàishēngwùbiāozhìwùjiǎncèzhōngdejìnzhǎn |